Genpact LTD (G) Stock Analysis and Metrics

Genpact

NYSE: G

$32.65 ▲ +1.39 (+4.43%)

At close: Jul 27, 2026 · 2:55 PM UTC

Financial Ratios

Market Cap5.56 Bn

P/E9.75

P/S1.08

Div. Yield0.02

ROIC (Qtr)0.00

Total Debt (Qtr)1.54 Bn

Revenue Growth (1y) (Qtr)6.68

Add ratio to table…

About

Genpact is an agentic and advanced technology solutions company that combines deep industry knowledge process intelligence and last mile expertise to deliver innovative solutions for enterprises worldwide. It operates in the business process services and technology consulting industry.

Genpact generates revenue by providing Advanced Technology Solutions and Core Business Services to clients across multiple industries. Advanced Technology Solutions comprises Data and AI Digital Technology Advisory Services and Agentic Solutions while Core Business Services comprises Decision Support Services Technology Services and Digital Operations. In 2025 Advanced Technology Solutions generated 1.2 billion dollars representing 23.7 percent of net revenues and Core Business Services generated 3.9 billion dollars representing 76.3 percent of net revenues.

The company operates through the following segments: Financial Services Consumer and Healthcare and High Tech and Manufacturing.

• Financial Services provides Advanced Technology Solutions and Core Business Services to banking capital markets and insurance clients including retail and commercial banks fintech companies payment providers wealth and asset management firms broker dealers exchanges auto finance providers clearing settlement organizations renewable energy lenders insurers brokers agents reinsurers and insurtech companies offering services such as customer onboarding customer service collections loan operations payment processing mortgage origination servicing compliance wealth management capital market support fraud detection anti money laundering transaction monitoring know your customer due diligence sanctions screening insurance policy underwriting new business processing policy administration claims management catastrophe exposure or risk modeling actuarial services and end to end third party administration.

• Consumer and Healthcare delivers Advanced Technology Solutions and Core Business Services to consumer goods retail life sciences and healthcare clients including food and beverage household goods personal care apparel companies grocery chains general and specialty retailers pharmaceutical medical technology medical device biotechnology firms retail pharmacies distributors diagnostic labs healthcare payers and providers offering services such as demand generation sensing planning supply chain management pricing trade promotion deduction recovery order management digital commerce customer experience regulatory affairs lifecycle management chemistry manufacturing controls compliance regulatory information management claim lifecycle management claims processing adjudication recovery payment integrity revenue cycle management health equity analytics care services and customer experience.

• High Tech and Manufacturing provides Advanced Technology Solutions and Core Business Services to high tech hardware software and manufacturing clients including information and digital technology software digital platform social media electronics semiconductor enterprise technology media communications services hospitality firms aerospace automotive mobility chemicals energy electric vehicles batteries industrial machinery materials transportation logistics oil gas and utilities companies offering services such as trust and safety advertising sales support customer user experience customer care support supply chain management direct and indirect procurement logistics field aftermarket support engineering services.

Genpact holds a strong position in the global business process services and technology consulting market competing with large multinational accounting and consulting firms low cost country business process providers information technology transformation companies and niche specialist vendors. Its competitive advantages stem from deep industry and functional domain expertise the ability to advise clients on process transformation that drives business value the capacity to deliver innovative agentic and advanced technology solutions access to data artificial intelligence and technology talent a track record of digital transformation and continuous process improvement strong reputation and client references flexible commercial models broad service scope high quality solutions long term client relationships and worldwide scale.

Genpact serves a diverse customer base that includes many of the world's largest enterprises approximately one quarter of the Fortune Global 500 companies as well as smaller emerging disruptors across industries such as financial services consumer and healthcare and high tech and manufacturing.

Investment Thesis

▲ Bull case

Genpact Limited is capturing significant structural advantages from the accelerating adoption of agentic AI solutions, where revenue per headcount exceeds twice that of the total company and gross margin expansion is now in its twelfth consecutive quarter, rising 110 basis points to 36.4%. This margin improvement is not merely cyclical but reflects a fundamental shift toward high-value Advanced Technology Solutions (ATS), which grew 24% year-over-year and now constitutes 27% of total revenue. The company’s 70/70 metric—70% of ATS revenue from amortized and non-FTE models—creates predictable, sticky annuity-like cash flows that are increasingly decoupled from headcount growth, enabling operational leverage as AI agents handle routine tasks while human experts focus on validation and model refinement. Management explicitly noted that agentic solutions generated nearly double the total contract value in Q1 versus all of 2025, with over 50% of cumulative awarded value coming from new clients, signaling expanding market share and reduced reliance on legacy accounts. The strategic alliance with Google Cloud for CFO-focused AI solutions is not merely a marketing partnership but a production-scale deployment already yielding measurable outcomes in credit memo processing for clients like Cardinal Health, with touchless processing gains and improved cash flow—evidence that the alliance is moving beyond pilot phases into enterprise-scale implementation. This positions Genpact to monetize its proprietary process intelligence at scale, a moat difficult for pure-play AI vendors to replicate without decades of domain expertise in finance, supply chain, and healthcare operations. The HFS Research recognition as a Horizon 3 GCC Orchestrator further validates Genpact’s unique ability to orchestrate Global Capability Centers by combining process intelligence, agentic AI, and platform delivery—transforming GCCs from cost centers into strategic nerve centers that unlock scalable, AI-enabled value. This differentiation allows Genpact to command premium pricing in complex, regulated industries where clients require not just technology but deep operational context to drive outcomes, a capability that competitors lacking Genpact’s heritage cannot easily match. With record backlog, six large deals signed ($50M+ each), and a pipeline growing over 30% in the last 90 days, the company has multi-year visibility into ATS-driven revenue, supporting its full-year outlook of at least 7% total revenue growth and 20% ATS growth. The early signs of revenue growth outpacing headcount—cited by management as a productivity leverage from AI-led solutions—suggest that margin expansion could exceed current guidance if adoption accelerates, particularly as non-FTE revenue (now 48% of total) continues to shift contracts toward outcome-based models that are less sensitive to wage inflation and labor constraints. Genpact is not merely adapting to AI disruption but is actively reshaping its business model around it, creating a self-reinforcing flywheel where domain expertise improves AI outcomes, which in turn attracts more clients and deepens partnerships, all while expanding its addressable market beyond traditional BPO into enterprise AI transformation.

Genpact Limited is capturing significant structural advantages from the accelerating adoption of agentic AI solutions, where revenue per headcount exceeds twice that of the total company and gross margin expansion is now in its twelfth consecutive quarter, rising 110 basis points to 36.4%. This margin improvement is not merely cyclical but reflects a fundamental shift toward high-value Advanced Technology Solutions (ATS), which grew 24% year-over-year and now constitutes 27% of total revenue. The company’s 70/70 metric—70% of ATS revenue from amortized and non-FTE models—creates predictable, sticky annuity-like cash flows that are increasingly decoupled from headcount growth, enabling operational leverage as AI agents handle routine tasks while human experts focus on validation and model refinement. Management explicitly noted that agentic solutions generated nearly double the total contract value in Q1 versus all of 2025, with over 50% of cumulative awarded value coming from new clients, signaling expanding market share and reduced reliance on legacy accounts. The strategic alliance with Google Cloud for CFO-focused AI solutions is not merely a marketing partnership but a production-scale deployment already yielding measurable outcomes in credit memo processing for clients like Cardinal Health, with touchless processing gains and improved cash flow—evidence that the alliance is moving beyond pilot phases into enterprise-scale implementation. This positions Genpact to monetize its proprietary process intelligence at scale, a moat difficult for pure-play AI vendors to replicate without decades of domain expertise in finance, supply chain, and healthcare operations. The HFS Research recognition as a Horizon 3 GCC Orchestrator further validates Genpact’s unique ability to orchestrate Global Capability Centers by combining process intelligence, agentic AI, and platform delivery—transforming GCCs from cost centers into strategic nerve centers that unlock scalable, AI-enabled value. This differentiation allows Genpact to command premium pricing in complex, regulated industries where clients require not just technology but deep operational context to drive outcomes, a capability that competitors lacking Genpact’s heritage cannot easily match. With record backlog, six large deals signed ($50M+ each), and a pipeline growing over 30% in the last 90 days, the company has multi-year visibility into ATS-driven revenue, supporting its full-year outlook of at least 7% total revenue growth and 20% ATS growth. The early signs of revenue growth outpacing headcount—cited by management as a productivity leverage from AI-led solutions—suggest that margin expansion could exceed current guidance if adoption accelerates, particularly as non-FTE revenue (now 48% of total) continues to shift contracts toward outcome-based models that are less sensitive to wage inflation and labor constraints. Genpact is not merely adapting to AI disruption but is actively reshaping its business model around it, creating a self-reinforcing flywheel where domain expertise improves AI outcomes, which in turn attracts more clients and deepens partnerships, all while expanding its addressable market beyond traditional BPO into enterprise AI transformation.

▼ Bear case

Genpact Limited’s bullish narrative around agentic AI and Advanced Technology Solutions may be overstated, as the company’s core business services—still 73% of total revenue—grew only 1.4% year-over-year, revealing minimal organic growth in its legacy operations despite heavy investment in transformation. This stagnation suggests that the shift to agentic models is not yet generating sufficient offsetting revenue to counteract the maturation of its traditional BPO footprint, and management’s reliance on non-FTE revenue (48% of total) as a growth lever may be misleading, as much of this shift could stem from contract renegotiations or pricing adjustments rather than genuine new demand for outcome-based models. The company’s gross margin expansion of 110 basis points, while positive, remains modest and may be partially driven by favorable mix shifts or one-time cost efficiencies rather than sustainable structural improvement, especially given that SG&A expenses rose to 20.9% of revenue—up from prior periods—indicating that disciplined investment in growth initiatives is actually increasing cost pressure, potentially undermining margin gains if ATS growth fails to scale as promised. Management’s claim of revenue decoupling from headcount lacks concrete quantification in the transcript; while they cite “early signs,” no specific metrics were provided on headcount growth versus revenue growth, leaving open the possibility that any leverage is marginal and not yet material enough to meaningfully impact profitability at scale. The strategic alliance with Google Cloud, while highlighted as a milestone, was described in broad terms without disclosure of financial terms, revenue contribution, or client adoption rates beyond a single example (Cardinal Health), raising concerns that it may be more aspirational than accretive in the near term—particularly given that Genpact’s partner-related revenue, though growing 35% year-over-year, still represents only 13% of total revenue, suggesting limited dependence on or success from ecosystem partnerships to date. Furthermore, the HFS Research recognitions, while positive, are third-party endorsements that do not guarantee translating into incremental contract wins or pricing power, and the company’s reliance on such external validations may signal a lack of internally demonstrable, quantifiable differentiation in a crowded AI services market where competitors like Accenture, IBM, and Cognizant are also heavily investing in agentic AI. The company’s adjusted diluted EPS growth of 16.7% outpacing revenue growth of 6.7% is partly driven by lower amortization of acquired intangibles (down from $4.3M to $3.1M) and favorable tax effects, which are not sustainable levers for long-term EPS expansion. Finally, the payment of $77.5M in earn-out consideration during the quarter—a non-recurring but significant cash outflow not highlighted in management’s prepared remarks—suggests potential liabilities from past acquisitions that could recur, and the company’s continued share repurchases ($70M) and dividends ($32M) amid only $24M of operating cash used (a seasonal outflow) imply reliance on cash reserves or debt to fund shareholder returns, which may constrain future flexibility if operating cash conversion deteriorates. Without clear evidence that agentic solutions are generating material, incremental revenue beyond cannibalizing legacy services or that partnerships are yielding scalable, high-margin outcomes, the market may be overestimating the pace and profitability of Genpact’s transformation.

Genpact Limited’s bullish narrative around agentic AI and Advanced Technology Solutions may be overstated, as the company’s core business services—still 73% of total revenue—grew only 1.4% year-over-year, revealing minimal organic growth in its legacy operations despite heavy investment in transformation. This stagnation suggests that the shift to agentic models is not yet generating sufficient offsetting revenue to counteract the maturation of its traditional BPO footprint, and management’s reliance on non-FTE revenue (48% of total) as a growth lever may be misleading, as much of this shift could stem from contract renegotiations or pricing adjustments rather than genuine new demand for outcome-based models. The company’s gross margin expansion of 110 basis points, while positive, remains modest and may be partially driven by favorable mix shifts or one-time cost efficiencies rather than sustainable structural improvement, especially given that SG&A expenses rose to 20.9% of revenue—up from prior periods—indicating that disciplined investment in growth initiatives is actually increasing cost pressure, potentially undermining margin gains if ATS growth fails to scale as promised. Management’s claim of revenue decoupling from headcount lacks concrete quantification in the transcript; while they cite “early signs,” no specific metrics were provided on headcount growth versus revenue growth, leaving open the possibility that any leverage is marginal and not yet material enough to meaningfully impact profitability at scale. The strategic alliance with Google Cloud, while highlighted as a milestone, was described in broad terms without disclosure of financial terms, revenue contribution, or client adoption rates beyond a single example (Cardinal Health), raising concerns that it may be more aspirational than accretive in the near term—particularly given that Genpact’s partner-related revenue, though growing 35% year-over-year, still represents only 13% of total revenue, suggesting limited dependence on or success from ecosystem partnerships to date. Furthermore, the HFS Research recognitions, while positive, are third-party endorsements that do not guarantee translating into incremental contract wins or pricing power, and the company’s reliance on such external validations may signal a lack of internally demonstrable, quantifiable differentiation in a crowded AI services market where competitors like Accenture, IBM, and Cognizant are also heavily investing in agentic AI. The company’s adjusted diluted EPS growth of 16.7% outpacing revenue growth of 6.7% is partly driven by lower amortization of acquired intangibles (down from $4.3M to $3.1M) and favorable tax effects, which are not sustainable levers for long-term EPS expansion. Finally, the payment of $77.5M in earn-out consideration during the quarter—a non-recurring but significant cash outflow not highlighted in management’s prepared remarks—suggests potential liabilities from past acquisitions that could recur, and the company’s continued share repurchases ($70M) and dividends ($32M) amid only $24M of operating cash used (a seasonal outflow) imply reliance on cash reserves or debt to fund shareholder returns, which may constrain future flexibility if operating cash conversion deteriorates. Without clear evidence that agentic solutions are generating material, incremental revenue beyond cannibalizing legacy services or that partnerships are yielding scalable, high-margin outcomes, the market may be overestimating the pace and profitability of Genpact’s transformation.

Geographical Breakdown of Revenue (2025)

Peer Comparison

Companies in the Information Technology Services

S.No.	Ticker	Company	Market Cap	P/E	P/S	Total Debt (Qtr)
1	IBM	International Business Machines Corp	204.15 Bn	10,207.31	2.95	61.99 Bn
2	ACN	Accenture plc	95.98 Bn	12.09	1.31	5.14 Bn
3	GIB	Cgi Inc	61.84 Bn	0.35	5.21	2.65 Bn
4	GDS	GDS Holdings Ltd	48.26 Bn	120.72	28.12	-
5	INFY	Infosys Ltd	48.00 Bn	0.15	0.04	-
6	CTSH	Cognizant Technology Solutions Corp	22.89 Bn	10.30	1.07	0.57 Bn
7	FIS	Fidelity National Information Services, Inc.	22.41 Bn	146.49	1.96	16.99 Bn
8	WIT	Wipro Ltd	20.42 Bn	14.44	1.97	1.88 Bn

Research Tools

Developers

About

Investment Thesis

Segments Breakdown of Revenue (2025)

Geographical Breakdown of Revenue (2025)

Peer Comparison

Research Tools

Developers

About

Investment Thesis

Segments Breakdown of Revenue (2025)

Geographical Breakdown of Revenue (2025)

Peer Comparison

Create an account

Sign In

Reset Password